Novartis dodges Trump’s drug tariff blitz with $23bn US reshoring plan
Find out how Novartis plans to produce all key medicines in the US through a $23B investment in 10 new and expanded facilities nationwide. Read More
Protecting Canada from space: How this C$72m contract to Spire Global could transform wildfire response
The Canadian Space Agency has assigned a C$72 million contract to Spire Global Canada, a subsidiary of Spire Global, Inc., to design and develop a ... Read More
Darktrace to acquire Cado Security, enhancing AI-driven cloud cybersecurity solutions
Darktrace, a globally recognized leader in artificial intelligence (AI) for cybersecurity, has announced its proposed acquisition of Cado Security, a UK-based specialist in cloud investigation ... Read More
AstraZeneca to bolster US footprint with multi-billion dollar strategy
In a bold move set to reshape the pharmaceutical landscape, AstraZeneca has announced a substantial $3.5 billion investment aimed at expanding its research and manufacturing ... Read More
Danaher wraps up $5.7bn acquisition of Abcam to bolster life sciences segment
Danaher Corporation (NYSE: DHR), a renowned global science and technology innovator, has announced the completion of its acquisition of Abcam plc (NASDAQ: ABCM), a key ... Read More
Danaher to acquire protein consumables supplier Abcam for $5.7bn
Danaher Corporation (NYSE: DHR), a global science and technology innovator, has announced a definitive agreement to acquire Abcam plc (NASDAQ: ABCM), a leading global supplier ... Read More
Boston mass shooting sends shockwaves, seven hospitalized amid Caribbean festival
In a horrifying turn of events that has shattered the city's festive spirit, at least seven people have been rushed to the hospital following a ... Read More
Microbiome company Vedanta Biosciences raises $68m in Series D
Vedanta Biosciences, a clinical-stage microbiome company founded by PureTech Health, has raised $68 million in a Series D financing round led by affiliates of Magnetar ... Read More
Nipocalimab developer Momenta Pharmaceuticals to be acquired by J&J
J&J acquisition of Momenta Pharmaceuticals : US healthcare giant Johnson & Johnson (J&J) has signed a $6.5 billion deal to acquire Momenta Pharmaceuticals, a biotech ... Read More
Precision oncology company Black Diamond Therapeutics raises $85m
Black Diamond Therapeutics, a precision oncology company based in Cambridge, has raised $85 million from a Series C financing round led by Boxer Capital of ... Read More